Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dustin D Ruff

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Urology|March 25, 2017
Prospective Case-crossover Study Investigating the Possible Association Between Nonarteritic Anterior Ischemic Optic Neuropathy and Phosphodiesterase Type 5 Inhibitor ExposureEvelyn M Flahavan, Hu Li, Komal Gupte-Singh, et al.
Headache|November 29, 2020
Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With MigraineJanet H Ford, Tobias Kurth, Amaal J Starling, et al.
Cephalalgia : an International Journal of Headache|November 4, 2020
Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraineDavid W Dodick, Erin G Doty, Sheena K Aurora, et al.
The Journal of Headache and Pain|February 26, 2020
Trajectory of migraine-related disability following long-term treatment with lasmiditan: results of the GLADIATOR studyRichard B Lipton, Louise Lombard, Dustin D Ruff, et al.
Cephalalgia : an International Journal of Headache|May 21, 2019
Efficacy of galcanezumab in patients with chronic migraine and a history of preventive treatment failureDustin D Ruff, Janet H Ford, Antje Tockhorn-Heidenreich, et al.
Expert Review of Neurotherapeutics|October 22, 2015
Atomoxetine monotherapy compared with combination therapy for the treatment of ADHD: a retrospective chart review studyDavid B Clemow, Oren W Mason, Elias H Sarkis, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|August 23, 2007
High-dose atomoxetine treatment of ADHD in youths with limited response to standard dosesChristopher J Kratochvil, David Michelson, Jeffrey H Newcorn, et al.
Journal of Child and Adolescent Psychopharmacology|November 6, 2007
Effects of atomoxetine on growth in children with attention-deficit/hyperactivity disorder following up to five years of treatmentThomas J Spencer, Christopher J Kratochvil, R Bart Sangal, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Urology|March 25, 2017
Prospective Case-crossover Study Investigating the Possible Association Between Nonarteritic Anterior Ischemic Optic Neuropathy and Phosphodiesterase Type 5 Inhibitor ExposureEvelyn M Flahavan, Hu Li, Komal Gupte-Singh, et al.
Headache|November 29, 2020
Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With MigraineJanet H Ford, Tobias Kurth, Amaal J Starling, et al.
Cephalalgia : an International Journal of Headache|November 4, 2020
Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraineDavid W Dodick, Erin G Doty, Sheena K Aurora, et al.
The Journal of Headache and Pain|February 26, 2020
Trajectory of migraine-related disability following long-term treatment with lasmiditan: results of the GLADIATOR studyRichard B Lipton, Louise Lombard, Dustin D Ruff, et al.
Cephalalgia : an International Journal of Headache|May 21, 2019
Efficacy of galcanezumab in patients with chronic migraine and a history of preventive treatment failureDustin D Ruff, Janet H Ford, Antje Tockhorn-Heidenreich, et al.
Expert Review of Neurotherapeutics|October 22, 2015
Atomoxetine monotherapy compared with combination therapy for the treatment of ADHD: a retrospective chart review studyDavid B Clemow, Oren W Mason, Elias H Sarkis, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|August 23, 2007
High-dose atomoxetine treatment of ADHD in youths with limited response to standard dosesChristopher J Kratochvil, David Michelson, Jeffrey H Newcorn, et al.
Journal of Child and Adolescent Psychopharmacology|November 6, 2007
Effects of atomoxetine on growth in children with attention-deficit/hyperactivity disorder following up to five years of treatmentThomas J Spencer, Christopher J Kratochvil, R Bart Sangal, et al.
Pageof 2